Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters

Overview of attention for article published in Frontiers in immunology, July 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 38,631 followers.

Cancer Immunotherapies: From Efficacy to Resistance Mechanisms 013 Not Only Checkpoint Matters https://t.co/eg9yXEXeWB

RT @FrontImmunol: New Research: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters: The immunothe…

RT @FrontImmunol: New Research: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters: The immunothe…

Frontiers | Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters | Immunology https://t.co/7Kt950gjeb

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.